Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(60.0%)
Phase 4
1(20.0%)
Phase 2
1(20.0%)
5Total
N/A(3)
Phase 4(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04278482Not ApplicableCompleted

Effects of the Consumption of a Supplement Rich in Docosahexaenoic Acid (DHA) From Algae

Role: collaborator

NCT04744233Not ApplicableCompleted

Bioavailability of Carotenoids From Orange Juice in a Cross-over Study in Healthy Subjects.

Role: collaborator

NCT02645006Phase 2Unknown

Workshop for Primary Prevention of Falls. CHANGING TO NEVER FALL. CTNF

Role: collaborator

NCT02101372Not ApplicableCompleted

Intervention Module AGES

Role: collaborator

NCT01418872Phase 4Completed

A Clinical Trial Of Two Educational Strategies In Cardiovascular Health In Child Population

Role: collaborator

All 5 trials loaded